vorasidenib
servier
['vorasidenib', 'indigo']
plenary session #asco2023 starting w/ outstanding work by dr.mellinghoff
indigo: a global, randomized, dbl-blinded, ph3 study of vorasidenib vs placebo in pts w/ residual or recurrent grade 2 glioma with an idh1/2 mutation largely improved pfs, ttni 
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow